Q32 Bio Inc (QTTB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 29,821 | -47,733 | -53,743 | -5,005 | -95,764 |
| Depreciation Amortization | 571 | 460 | 586 | -654 | 9,247 |
| Accounts payable and accrued liabilities | -2,110 | -1,043 | 2,033 | -981 | -2,487 |
| Other Working Capital | -4,038 | -9,637 | 26,315 | 3,350 | -41,803 |
| Other Operating Activity | -57,787 | -9,762 | 6,132 | -110,371 | 21,056 |
| Operating Cash Flow | $-33,543 | $-67,715 | $-18,677 | $-113,661 | $-109,751 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 20,000 | N/A | -91,999 | -48,392 |
| PPE Investments | 7,000 | -75 | -5 | -1,285 | -2,396 |
| Net Acquisitions | N/A | N/A | N/A | 130,000 | N/A |
| Investing Cash Flow | $7,000 | $19,925 | $-5 | $36,716 | $-50,788 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 7,000 | 5,500 | N/A | N/A |
| Debt Repayment | -3,125 | N/A | -5,200 | N/A | N/A |
| Common Stock Issued | N/A | 43,694 | 106 | 596 | 52,169 |
| Other Financing Activity | 0 | 44,444 | 0 | 0 | 0 |
| Financing Cash Flow | $-3,125 | $95,138 | $406 | $596 | $52,169 |
| Beginning Cash Position | 78,612 | 31,264 | 49,540 | 110,335 | 218,705 |
| End Cash Position | 48,944 | 78,612 | 31,264 | 33,986 | 110,335 |
| Net Cash Flow | $-29,668 | $47,348 | $-18,276 | $-76,349 | $-108,370 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,543 | -67,715 | -18,677 | -113,661 | -109,751 |
| Capital Expenditure | N/A | -75 | -5 | -1,285 | -2,396 |
| Free Cash Flow | -33,543 | -67,790 | -18,682 | -114,946 | -112,147 |